Family · Pharmaceutical analytical standards
Sitafloxacin
A fluoroquinolone antibiotic approved in Japan in 2008; it blocks the enzymes bacteria use to copy their DNA (DNA gyrase and topoisomerase IV) and is used for respiratory and urinary tract infections. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Besides Japan it is also marketed in Thailand, and it is being studied as a "rescue" therapy against strains of Helicobacter pylori resistant to other antibiotics.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
